• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Light-Responsive Nanomaterials for Cancer Therapy

    2022-08-17 01:51:08XuZhngShengWngGuohuiChengPengYuJinChng
    Engineering 2022年6期

    Xu Zhng, Sheng Wng,*, Guohui Cheng, Peng Yu, Jin Chng,b,*

    a School of Life Sciences, Tianjin University, Tianjin 300072, China

    b Tianjin Engineering Center of Micro–Nano Biomaterials and Detection–Treatment Technology, Tianjin 300072, China

    Keywords:Light-responsive Nanomaterials Cancer Phototherapy

    ABSTRACT Due to its unique advantages,which include minimal invasiveness and relative clinical safety,phototherapy is considered to be a promising approach for cancer treatment. However, the treatment efficacy of phototherapy is often restricted by the limited depth of light penetration and the low targeting effect of phototherapeutic agents.The emergence of light-responsive nanomaterials offers a possible approach to achieve enhanced phototherapy potency.This review summarizes the progress in biomedical applications of light-responsive nanomaterials for cancer therapy, which include photothermal therapy (PTT),photodynamic therapy(PDT),light-responsive molecule delivery,and light-controlled combination therapy. Future prospects are also discussed. This review aims to demonstrate the significance of lightresponsive nanomaterials in cancer therapy and to provide strategies to expand the applications of phototherapy.

    1. Introduction

    In recent years,phototherapy has received a great deal of attention due to its advantages of spatiotemporal addressability, minimal invasiveness, and relative clinical safety [1,2]. As early as 1903, Niels Ryberg Finsen—the founder of modern phototherapy—was awarded the Nobel Prize for treating a skin disease(lupus vulgaris) using sunlight and ultraviolet (UV) radiation[3,4]. Since then, phototherapy has been continuously developed in biomedical engineering to combat skin diseases (e.g., eczema,psoriasis, and itchy skin) and mood and sleep disorders (e.g., seasonal affective disorder[5,6],non-seasonal depression[7],and circadian rhythm sleep disorders [8]). With the aid of phototherapeutic agents, such as photosensitizers and photothermal conversion agents (PTCAs), phototherapy has also proved to be an effective approach to ablate tumors [9].

    Light sources that are commonly applied in cancer phototherapy include UV light (100–400 nm), visible light (400–760 nm),and near-infrared (NIR) light (760–1350 nm). However, due to the absorption of biological tissues, the widely used UV light and visible light have limited tissue penetration depth [10], which restricts traditional phototherapy to superficial tumors and may lead to the risk of relapse and metastasis [1,11]. In addition, low targeting efficiency caused by the nonspecific distribution of phototherapeutic agents is an important issue that must be addressed.Untargeted delivery of phototherapeutic agents in therapy procedures will not only lead to low bioavailability and poor efficacy,but also cause side effects.

    With the development of nanotechnology, various phototherapeutic nanoagents based on versatile nanomaterials have been exploited to overcome the abovementioned limitations in cancer phototherapy [12–14]. Nanoagents with a specific size range(20–200 nm) accumulate in tumor tissue due to the enhanced permeation and retention (EPR) effect [15–17]. Therefore, nanomaterials hold potential to serve as carriers to deliver therapeutic molecules such as photosensitizers, PTCAs, drugs, and genes to tumor tissue, thereby achieving targeted therapy and combination therapy [18–20]. In order to address the issue of limited light penetration depth in phototherapy, NIR-light-responsive nanomaterials have been developed. For example, PTCAs that can directly absorb NIR light and generate heat have been used for NIR-triggered photothermal therapy (PTT). Upconversion nanoparticles (UCNPs), which can absorb long-wavelength NIR light and emit specific short-wavelength UV or visible light, have been used as a transducer to realize deeper penetration [21,22].Thus, light-responsive nanomaterials offer the possibility of overcoming the obstacles in and expanding the applications of phototherapy.

    In this review, we summarize recent advances in lightresponsive nanomaterials for cancer therapy (Table 1 [23–47]).These nanomaterials can be applied in PTT,photodynamic therapy(PDT), light-responsive molecule delivery, and light-controlled combination therapy (Fig. 1). We also discuss current challenges and prospects in phototherapy. The purpose of this review is to emphasize the significant role of light-responsive nanomaterials in cancer phototherapy and to provide further directions to expand their applications.

    2. Light-responsive nanomaterials

    Light-responsive nanomaterials that are used in cancer phototherapy include PTCAs,nanophotosensitizers,and nanoplatforms containing light-responsive moieties. PTCAs are agents that can capture light energy and convert it into heat to trigger cancer cell death. In general, PTCAs can be divided into two categories:organic materials and inorganic materials. Common organic PTCA materials include organic dye molecules (e.g., indocyanine green(ICG)) and organic nanoparticles (NPs) (e.g., semiconducting polymer NPs) [48,49]. Inorganic PTCA materials include noble metal materials (e.g., gold (Au) nanomaterials), transition metal chalcogenides and oxides (e.g., copper sulphide (CuS) NPs), and carbonbased materials (e.g., graphene oxide) [50].

    Photosensitizers can be activated by light with a specific wavelength to generate reactive oxygen species(ROS)and damage cancer cells through local oxidative stress [51]. Photosensitizers can also be divided into organic materials and inorganic materials.Organic photosensitizers include organic dye molecules such as porphyrin and boron-dipyrromethene (BODIPY), while inorganic photosensitizers include titanium dioxide (TiO2), zinc oxide(ZnO), graphitic carbon nitride (g-C3N4), and more [52,53].

    Table 1 Summary of light-responsive nanomaterials in cancer therapy.

    Fig. 1. Schematic illustration of applications of light-responsive nanomaterials in cancer therapy. NPs: nanoparticles.

    Many light-responsive nanoplatforms have been designed and developed by exploiting light-responsive linkers, such as azobenzene[54].These nanoplatforms can be used as efficient nanocarriers to realize light-responsive molecule delivery. In addition to designing such nanoplatforms to directly respond to light, lightresponsive nanomaterials can be designed to respond via a cascade strategy[55].For example,nanomaterials composed of photothermal agents (PTAs) and thermal-sensitive linkers can respond to light irradiation. Moreover, light-induced ROS generation can lead to the cleavage of some chemical bonds,such as thioketal(TK)linkers, thereby achieving light-triggered drug release [56].

    3. Photothermal therapy

    PTT is a promising treatment with minimal invasiveness and high therapeutic effects in cancer therapy [57]. Under irradiation by external light, PTCAs absorb light energy and convert it into heat, which kills cancer cells. PTCAs usually need to have high NIR absorption and high photothermal conversion efficiency. In the past decades, various nanomaterial-based PTCAs, such as Au nanomaterials, black phosphorus (BP), niobium carbide, graphene,metallic/nonmetallic compounds, and organic dye, have been developed for PTT [23–26,58–60]. For example, El-Sayed et al.[61] reported that gold nanorod (GNR)-assisted plasmonic PTT is a potential and effective alternative to traditional surgery.Furthermore,GNR PTT can decrease the collective migration of cancer cells by regulating and remodeling actin filaments and cell junction proteins [62]. De Sio et al. [27] reported a keratin-coated biomimetic gold NP (Ker-AuNP) that can be used as a highly efficient PTCA for plasmonic PTT.

    Zhang et al. [28] developed an inorganic nanotheranostic agent (Gd:CuS@bovine serum albumin (BSA) NPs) based on gadolinium (Gd)-integrated copper sulphide (CuS) NPs (Fig. 2(a)). Due to the strong NIR absorbance of the Gd:CuS NPs [63–65] and the good biocompatibility achieved by the BSA modification [66], the nanotheranostic agent (Gd:CuS@BSA NPs) can be used as an excellent nanotheranostic agent for in vivo photoacoustic (PA)/magnetic resonance imaging (MRI) guidance and effective PTT. As shown in Fig. 2(b), under NIR laser irradiation,the temperature of the Gd:CuS@BSA NPs clearly increased, indicating the good photothermal effect of Gd:CuS. Moreover, the Gd:CuS@BSA NPs exhibited the continuous enhancement of in vivo PA/MRI signals within 24 h on tumor-bearing mice(Fig. 2(c)). Dual-modal imaging facilitated imaging-guided phototherapy, resulting in potent tumor elimination. To verify the PTT effect of the Gd:CuS@BSA NPs in vitro, a cytotoxicity study and live/dead cell co-staining were carried out on SK-OV-3 cells.As shown in Figs. 2(d) and (e), the relative viabilities of the tumor cells were obviously decreased upon laser irradiation,which demonstrated the tumor-ablation effect of Gd:CuS@BSA.The photothermal effect of Gd:CuS@BSA was also demonstrated in vivo. As shown in real-time thermal images (Fig. 2(f)), when treated with Gd:CuS@BSA NPs, the temperature of the tumor sites increased by 21°C, which was significantly higher than the temperature increase in the control group (6°C). Under NIR laser irradiation, the tumor exhibited remarkable regression, followed by complete elimination (Fig. 2(g)), which demonstrated the significant tumor-ablation effect of PTT.

    Apart from inorganic nanomaterials, organic nanoagents play essential roles in cancer PTT. For example, US Food and Drug Administration (FDA)-approved ICG, a highly biocompatible NIR organic dye, has been widely applied in PTT due to its various energy level transition pathways upon NIR light excitation[67,68]. In addition, Pu et al. [29] reported semiconducting polymer nanoenzymes (SPNs) with an NIR photothermic effect for enhanced cancer therapy. As shown in Fig. 3(a), the SPNs contain a semiconducting polymer amphiphile (PCB) as a photothermal nanotransducer and bromelain (Bro) as a temperature-sensitive enzyme. Under NIR laser irradiation, the local temperature increased due to the photothermal conversion activity of the SPNs,leading to the photothermic activation of Bro. Therefore, collagen,the most abundant protein in the tumor extracellular matrix [69],was digested in situ,resulting in the improved tumor accumulation of SPNs and enhanced PTT.Upon 808 nm laser irradiation,the temperatures of the PCB1-Bro group were obviously increased, both in vitro (Fig. 3(b)) and in vivo (Fig. 3(c)), which verified the high photothermal conversion efficiency of PCB1-Bro. Moreover, the penetration depth of PCB1-Bro with NIR laser irradiation was evidently enhanced in comparison with the penetration depth without laser irradiation, confirming that photothermal-enhanced collagen digestion had occurred. As shown in Fig. 3(d), after the photothermic activation of the Bro enzyme,the tumor fluorescence signals of the PCB1-Bro-treated group were higher than those of other groups, indicating enhanced tumor accumulation of PCB1-Bro due to collagen digestion. The efficient accumulation of PCB1-Bro further led to a higher tumor temperature and stronger tumor growth inhibition (Figs. 3(c) and (e)).

    Fig.2. (a)Schematic illustration of Gd:CuS@BSA hybrid theranostic agents for imaging-guided tumor PTT.MRI:magnetic resonance imaging.(b)Infrared thermal images of an aqueous Gd:CuS@BSA NPs droplet of a Gd:CuS@BSA NP and a deionized water droplet with NIR laser irradiation(980 nm).(c)PA/MRI(dual-modal imaging)of an SK-OV-3 tumor before and after Gd:CuS@BSA treatment. (d)Viability of SK-OV-3 cells treated with Gd:CuS@BSA NPs and laser irradiation (980 nm, 0.6 W?cm-2,5 min).Ctrl: control group(treated with 0 μg?mL-1 Gd:CuS@BSA NPs).(e)Fluorescence staining of live/dead SK-OV-3 cells after treatment with different formulations.(f)In vivo thermal imaging of an SK-OV-3 tumor treated with different formulations followed by laser irradiation (980 nm, 5 min). (g) Growth curves of an SK-OV-3 tumor treated with different formulations. Reproduced from Ref. [28] with permission of American Chemical Society, ? 2016.

    Due to the advantages of PTT,some PTCAs have already entered clinical trials. In 2019, the results of a phase I trial demonstrated the feasibility of an approach involving gold–silica nanoshells for the focal PTT ablation of prostate tumors[70].In addition,in order to further improve the light penetration depth, NIR-II lightresponsive PTCAs have gained increased research attention. For example, Yang et al. [71] developed a polyethylene glycol-graftpolyethylenimine-modified hollow carbon nanosphere for NIR-II laser-activated cancer PTT.

    4. Photodynamic therapy

    PDT is a clinically approved modality that has been used for more than 40 years in the treatment of cancers, including superficial skin lesions, esophageal tumors, and lung tumors [48]. There are three essential elements in PDT: oxygen, a photosensitizer,and light [72]. Hundreds of photosensitizers have been applied for PDT clinically or preclinically, including porphyrin, chlorin,and phthalocyanine derivatives[73,74].In a conventional PDT process, photosensitizers transfer light energy to surrounding molecules to generate cytotoxic ROS for cancer treatment [75–77].There are two main types of photodynamic reaction—type I and type II. In the mechanism of a type I reaction, a triplet-state photosensitizer reacts with cellular substrates directly via electron transfer,resulting in the generation of free radicals.The generated radicals then react with oxygen (O2) to produce oxygenated products, including superoxide anions (O2-), hydrogen peroxide(H2O2),and hydroxyl radicals (·OH). Alternatively, in the mechanism of a type II reaction, a triplet photosensitizer transfers energy directly to oxygen (3O2) to produce highly reactive singlet oxygen (1O2)[14,73,76]. Most of the existing PDT systems adopt the oxygendependent type II mechanism [78].

    Fig. 3. (a) Schematic illustration of PCB1-Bro for photothermally enhanced NP accumulation in tumors. EDC/NHS: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/Nhydroxysuccinimide. (b) Temperature changes of different samples upon laser irradiation. (c) Infrared thermal images of 4T1 tumor-bearing mice treated with different formulations and laser irradiation (808 nm, 5 min). (d) Real-time fluorescence images of 4T1 tumor-bearing mice treated with different formulations with/without laser irradiation. (e) Growth curves of a 4T1 tumor with different treatments. PBS: phosphate buffered saline. Reproduced from Ref. [29] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Compared with other conventional therapeutic methods, PDT possesses several advantages, including minimal invasiveness, the spatial accuracy of the operation, minimal side effects, non-drug resistance, and a short recovery period [79]. However, PDT also has major restrictions,including the hypoxic condition of the tumor,the low targeting efficiency of the photosensitizer,and limited light penetrationdepth.In addition,the nonspecific distributionof photosensitizers causes phototoxicity in normal tissues, which must be taken into consideration. Due to stringent requirements regarding biocompatibility and the frontier orbitals of the molecular motifs,the choice of efficient molecular photosensitizers remains limited[30].To address these problems,many novel photosensitizers with versatile properties have been developed to enhance the efficacy of PDT. For example, porous covalent organic frameworks (COFs)with excellent ROS production efficiency have been developed by linking ROS-inert molecular motifs [30]. To enhance the effects of PDT in deep tissues, a combination of UCNPs and photosensitizers is an efficient approach[80].Xing et al.[81]proposed a strategy to achieve highly efficacious PDT by integrating UCNPs with graphene quantum dots(GQDs).UCNPs can serve as light transducers to convert NIR light into visible light for photosensitizer activation, thus greatly expanding the applicability of PDT.

    Moreover, some studies have demonstrated that the radicals generated via a type I photoreaction can amplify PDT response,especially under hypoxic conditions [82]. Based on this, Yoon et al. [83] reported a nanostructured phthalocyanine assembly(NanoPcA), which has a favorable antibacterial effect through enhanced type I PDT. Jiang et al. [31] developed a type I nanoagent—namely, dihydrolipoic-acid-coated gold nanoclusters(AuNC@DHLA)—for two-photon anticancer PDT.In this nanoagent,Au nanoclusters are used as a promising photosensitizer due to their excellent biocompatibility and long fluorescence tripletstate lifetime [84]. In another study, Lin et al. [32] reported a nanoscale metal–organic framework (NMOF) based on 5,10,15,20-tetra (p-benzoato) bacteriochlorin (TBB) ligands(denoted as Zr-TBB) for enhanced PDT via both type I and type II mechanisms(Fig.4(a)).As a nanophotosensitizer,NMOF possesses the unique properties of high photosensitizer loading efficacy, a porous structure, and intrinsic biodegradability[85].Bacteriochlorin exhibits excellent absorption in the NIR region (700–850 nm)and can be used for type I PDT under hypoxic conditions [86].However, the PDT efficacy of bacteriochlorin is significantly restricted by its instability to oxygen and light [87,88]. The structure of NMOF is beneficial for stabilizing bacteriochlorin’s ligands,thereby preventing unimolecular photodecomposition and selfquenching. As shown in the confocal laser scanning microscopy(CLSM) images in Fig. 4(b), four types of ROS (O2-, H2O2,·OH, and1O2) were produced in the Zr-TBB group, confirming the presence of light-induced type I and type II PDT processes. Accordingly,Zr-TBB exhibits excellent in vivo antitumor efficacy against both subcutaneous 4T1 and MC38 tumors (Fig. 4(c)).

    Traditional photosensitizers, such as porphyrin derivatives, are hydrophobic and tend to aggregate in aqueous solution.The aggregation state of photosensitizers causes fluorescence quenching,which reduces the ROS production efficiency and greatly limits the PDT treatment outcome [89,90]. To address this issue, Chen et al.[91]developed a single molecular nanophotosensitizer based on a porphyrin nanocage. Due to the rigid structure of the nanocages, the π–π stacking interaction between the photosensitizers is inhibited, which promotes the photosensitizing effect.

    The development of aggregation-induced emission(AIE)photosensitizers provides another strategy to overcome the quenching effect of traditional photosensitizers [92,93]. Recently, Tang et al.[33]proposed a ‘‘1 + 1 +1 >3” synergistic strategy based on three AIE luminogens(AIEgens).The AIEgens have the same photosensitizer backbone but different targeting groups that can target mitochondria, the cell membrane, and lysosomes, respectively (Fig.5(a)). As shown in Fig. 5(b), after cellular uptake by 4T1 cells, the three AIEgens manifested excellent co-localization with corresponding organelles. The tumor-inhibition effect of this three-inone group was found to be better than that of each photosensitizer alone, which was ascribed to the synergistic PDT strategy (Fig.5(c)).

    Due to the nonspecific biodistribution of photosensitizers,most photosensitizers will trigger phototoxicity when patients are exposed to sunlight. To reduce the phototoxicity, activatable PDT is a promising strategy. For example, Li et al. [34] developed an AIE-photosensitizer-loaded liposome (AIE-PS@liposome) to achieve controlled photosensitization. As shown in Fig. 5(d), the photosensitivity of the AIE-PS entrapped in the lipid bilayer is in an ‘‘OFF” state; however, once the AIE-PS@liposomes reach tumor sites, the AIE-PS are released for in situ reaggregation, leading to activated PDT.As expected,the AIE-PS@liposomes exhibited much lower phototoxicity under both laser and sunlight irradiation in comparison with the control groups, which included AIE-PS nanoaggregates and the commercial photosensitizer chlorin e6(Ce6) (Fig. 5(e)).

    5. Light-responsive molecule delivery

    The low targeting of therapeutic agents in cancer therapy results in unsatisfactory efficacy and severe side effects in normal tissues. With the development of stimuli-responsive delivery systems, an increasing number of nanocarriers based on polymeric and inorganic nanomaterials have been exploited to realize the targeted delivery of drugs, photosensitizers, genes, and so forth [94–98]. As an external stimulus, light has unique features for controlling the release behaviors of therapeutic agents at precise locations and avoiding individual variability [35,99]. For example, thermalresponsive nanomaterials can achieve light-triggered drug delivery via photothermal-induced linker cleavage, structural changes in nanocarriers, radical generation, and other pathways [36–39].The ROS produced by photosensitizers under light irradiation can also lead to on-demand drug delivery by triggering the cleavage of ROS-sensitive linkers, such as TK linker [40,100].

    Fig.4. (a)Schematic illustration of bacteriochlorin ligands stabilized in Zr-TBB for type I and type II PDT.(b)CLSM images of ROS generation in 4T1 cells treated with different formulations after light irradiation.Scale bars:20 μm.(c)Growth curves of a 4T1 tumor and an MC38 tumor treated with different formulations.Reproduced from Ref.[32]with permission of American Chemical Society, ? 2020.

    Fig. 5. (a) Chemical structures and schematic illustration of three AIEgens for synergistically enhanced PDT. (b) Co-localization of the AIEgens in CLSM images of 4T1 cells treated with different formulations.(c)Growth curves of a 4T1 tumor treated with different formulations.(d)Schematic illustration of AIE-PS@liposomes for activatable PDT.DSPE-PEG: distearoylphosphatidylethanolamine-poly(ethylene glycol) 2000; DMPC: 1,2-dimyristoyl-sn-glycero-3-phosphocholine. (e) Blood vessels in ears treated with different formulations. (a)–(c) Reproduced from Ref. [33] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2020; (d) and (e) reproduced from Ref. [34] with permission of American Chemical Society, ? 2019.

    Liang et al. [41] developed diazirine (DA)-decorated human serum albumin (HSA) nanomedicines (denoted as HSA dNMs) for the co-encapsulation of photosensitizer(ICG)and the prodrug tirapazamine (TPZ) via electrostatic and hydrophobic interactions(Fig. 6(a)). As shown in Fig. 6(b), under 405 nm laser irradiation,the DA groups transformed into reactive carbine moieties and reacted with the adjacent HSA dNMs for crosslinking, leading to improved tumor accumulation and retention of ICG/TPZ@HSA dNMs. Next, 808 nm laser irradiation triggered hyperthermia and ROS generation for tumor PTT and PDT. In addition, the oxygen consumption in the PDT process led to hypoxia aggravation and TPZ activation to achieve synergistic therapy. The lightresponsive delivery of HSA dNMs was confirmed by both in vitro and in vivo results.The size of the HSA dNMs with DA modification was clearly increased after exposure to a laser at 405 nm(Fig.6(c)),which verified the UV-light-triggered aggregation behavior. The tumor accumulation of the ICG/TPZ@HSA dNMs in vivo was represented by the imaging contrast index (CI) calculated from the fluorescent signal ratio of tumor to tissue [101]. The CI values of the UV-laser-treated group were significantly higher than those of the control group without laser irradiation, confirming the laserenhanced tumor accumulation behavior of the ICG/TPZ@HSA dNMs(Fig. 6(d)).Consistent results were obtained,based on biodistribution fluorescence images. As shown in Fig. 6(e), the fluorescence intensity of the tumors was significantly increased after laser treatment. This elaborate design of ICG/TPZ@HSA dNMs enhanced the targeted delivery of ICG/TPZ and improved the anticancer efficacy through light-induced aggregation and cascade phototherapy/chemotherapy.

    Aside from the delivery of drugs and photosensitizers,nanomaterials can be applied for the light-controlled selective activation of gene expression in gene therapy. For example, optogenetics is a combination of optical and genetic methods to precisely control the expression of proteins in specific cells,so as to control intracellular biological processes and behaviors [102]. Like most lighttriggered delivery systems that rely on UV/visible light irradiation,the activation of the photo-actuator in optogenetics is seriously restricted by the limited light penetration depth [103–105]. To address this issue, UCNPs can serve as a nanotransducer to transform external NIR light with deep penetration depth into local UV/visible light for the noninvasive activation of photoreceptors in vivo [106,107].

    Fig.6. Light-responsive drugs/photosensitizers delivery system for cancer therapy.(a)Schematic illustration of ICG/TPZ@HSA dNMs for cascaded synergistic cancer therapy triggered by laser irradiations(405 and 808 nm).CT:chemotherapy.(b)Scheme of 405 nm laser-induced aggregation of ICG/TPZ@HSA dNMs.(c)Size changes of HSA dNMs with different sequential laser irradiation times. (d) Tumor accumulation of ICG/TPZ@HSA dNMs, as represented by CI values. (e) In vivo biodistribution of ICG/TPZ@HSA dNMs in 4T1 tumor-bearing mice. T/N: the fluorescence signal ratio of tumor to tissue; p.i.: postinjection. Reproduced from Ref. [41] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Chang et al. [108] developed an upconversion optogenetic nanosystem composed of UCNPs, arabidopsis flavoprotein cryptochrome 2 (Cry2), and its interacting partner Cib1 plasmids. The UCNPs play a part in both plasmid DNA (pDNA) delivery and light transformation. External NIR-light-triggered local blue light emitting noninvasively induces photoreceptor Cry2 and Cib1 interaction, which activates the apoptotic signaling pathway of cancer cells. In another effort, Chang’s group [35] reported on an NIRcontrolled gene-delivery system based on mesoporous silica(mSiO2)@polyethyleneimine (PEI) nanocarrier-conjugated upconverting rods (UCRs) (Fig. 7(a)). Upon NIR light irradiation, the external NIR light is converted into UV light by the UCRs to trigger the cleavage of o-nitrobenzyl groups (Fig. 7(b)). As a result, the gene-loaded mSiO2@PEI nanocarriers are released for gene delivery(Fig.7(c)).This gene expression study reported that the genes were released and expressed upon NIR irradiation,confirming that lightcontrolled precisely regulated gene expression at high spatial and temporal resolutions had been achieved.

    6. Light-controlled combination therapy

    Although phototherapy techniques have been developed in recent years,some drawbacks of single-mode phototherapy,which relies on only one therapeutic method,remain to be resolved,such as relapse or metastasis in the treatment of persistent tumors [1].To address this issue, combination phototherapy with immunotherapy, gene therapy, chemotherapy, chemodynamic therapy (CDT), and other therapy methods can maximize the advantages of each therapeutic pattern and achieve complementary multitherapeutic efficacy [109,110].

    Photo-immunotherapy, which can eliminate primary tumors and induce host immunity in order to control distant metastases,is considered to be a promising strategy for the treatment of metastatic cancer [111]. For example, Wang et al. [42] developed an injectable red blood cell (RBC)-based gel for cancer photoimmunotherapy. After the subcutaneous injection of imiquimod(R837) adjuvant engineered RBCs, a hydrogel-like composition spontaneously formed due to the infiltrated platelets and thrombin. The photothermal effect of the in situ-formed RBC gel led to the photoablation of tumors and the production of tumorassociated antigens,thereby initiating adaptive immune responses to cancer.Moreover,the released immunoadjuvant,R837,induced robust and persistent immune responses for cancer metastasis/recurrence inhibition.

    Liang et al.[43]developed an‘‘a(chǎn)ll-in-one”theranostic nanomedicine based on CuInS/ZnS(ZCIS)quantum dots(QDs)for synergistic PTT/PDT therapy. QDs have been widely used in tumor diagnosis and treatment due to their high fluorescence intensity and broad excitation spectrum [44,112,113]. The efficient absorption effect of ZCIS QDs in the range of 650–750 nm has enabled noninvasive fluorescence/multispectral optical tomography imaging. Furthermore, the photothermal and photodynamic effects of ZCIS QDs could be used for cancer treatment (Fig. 8(a)).

    In addition,Chang et al.[45]reported a multifunctional nanotheranostic agent (PB@PEI/HSP70-p53-GFP NP) based on human HSP70 promoter-loaded Prussian blue (PB) nanocubes for NIR light-triggered PTT/gene combination therapy. As shown in Fig.8(b), due to the photothermal property of the PB nanocubes, the HSP70 promoter was activated under mild NIR laser irradiation(≈41°C),resulting in tumor suppressor p53-dependent apoptosis.Under strong NIR laser irradiation (≈50°C), both PTT and gene therapy were activated. Thus, the synergistic antitumor efficacy can be adjusted by the NIR laser irradiation.

    Fig. 7. Light-responsive gene delivery and expression. (a) Synthetic procedure for the mSiO2@PEI gene nanocarrier and the UCR substrate. APTES: 3-aminopropyl triethoxysilane;TEOS:tetraethyl orthosilicate;PAA:poly(acrylic acid).(b)Schematic illustration of the light-triggered release of mSiO2@PEI gene nanocarriers from the UCR substrate due to photocleavage of o-nitrobenzyl groups. (c) Fluorescence images of the substrate immobilized with rhodamine-loaded mSiO2@PEI nanocarriers with or without NIR laser (980 nm, 8.9 W?cm-2, 12 min). Reproduced from Ref. [35] with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2015.

    The combination of chemotherapy and phototherapy is another important approach to realize synergistic therapy. Qian et al. [46]developed an ROS-responsive prodrug delivery nanoplatform for a combination of chemotherapy and PDT. As shown in Fig. 8(c),the chemotherapeutic drug camptothecin(CPT)and the photosensitizer pyropheophorbide-a (PPa) were conjugated to methoxypolyethylene glycol (MPEG) to prepare a polyprodrug, which further self-assembled into nanomedicine. The fluorescent PPa precisely located the tumor site and guided laser irradiation. Next,the ROS generated from the PPa-mediated PDT process broke the ROS-responsive TK linker between the polymer and CPT, leading to controlled release of the CPT drugs. This combination of chemotherapy and PDT exhibited a more effective antitumor effect than monotherapy.

    Similar to PDT, CDT involves the generation of highly oxidative hydroxyl radicals for tumor treatment [114–117]. Tang et al. [47]constructed a programmed release system (NMOF@dihydroartemisinin (DHA)@calcium carbonate (CaCO3)) based on DHA-loaded ferrum(Fe)-(4,4,4,4-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)) (TCPP)NMOF with CaCO3mineralized coating(Fig.8(d)).The weak acidity of the tumor microenvironment led to the dissolution of the CaCO3layer, resulting in Ca2+release. Once the NMOF@DHA entered cancer cells, the high glutathione (GSH)level inside the cells led to Fe3+reduction and TCPP activation,due to NMOF skeleton collapse. Therefore, NMOF@DHA@CaCO3was able to realize Ca2+-DHA-mediated oncosis therapy, Fe2+-DHA-mediated CDT, and TCPP-mediated PDT.

    7. Conclusions and future perspectives

    Light-induced phototherapy has been widely used to combat cancers due to its minimal invasiveness and minor side effects[118]. However, the efficacy of phototherapy is restricted by the limited depth of light penetration and the untargeted distribution of phototherapeutic agents. The emergence of light-responsive nanomaterials provides a promising approach to address these issues due to the specific properties of such nanomaterials, which include their nanoscale size,multifunctional surface modifications,and controllable synthesis.As a result,enhanced phototherapy has been achieved through the rational design of light-responsive nanomaterials.

    This review summarized recent advances in light-responsive nanomaterials for cancer therapy, including PTT, PDT, lightresponsive molecule delivery, and light-controlled combination therapy. To achieve precise cancer phototherapy and accelerate clinical transformation, the following aspects should be taken into consideration:

    (1) Limitation of light penetration depth. The penetration depth of light relies on the light wavelength. UV light and visible light are mainly applied in the treatment of superficial skin diseases due to their limited penetration depth. In addition, light is attenuated to a large extent when it interacts with tissues, which hinders the applications of phototherapy, especially in the treatment of deep-tissue tumors. Although the application of UCNPs provides an approach to increase light penetration depth, UCNPs still have the disadvantage of low conversion efficiency.Compared with the NIR-I window(750–1000 nm),the NIR-II window(1000–1350 nm) exhibits reduced light scattering, minimized tissue absorption,and higher maximum permissible laser exposure;thus,it seems to be a prospective candidate for achieving deep-tissue penetration depth [119,120]. Therefore, NIR-II-responsive nanomaterials show great potential for expanding the application of phototherapy.

    Fig.8. Light-controlled combination cancer therapy.(a)Schematic illustration of ZCIS QDs in the combination therapy of PTT and PDT.FL:fluorescence;MSOT:multispectral optoacoustic tomography; US: ultrasound;ΔT: temperature increase. (b) Schematic illustration of PB@PEI/HSP70-p53-GFP NPs in the combination therapy of gene therapy and PDT. (c) Schematic illustration of MPEG–(TK–CPT)–PPa in the combination therapy of chemotherapy and PDT. (d) Schematic illustration of NMOF@DHA@CaCO3 in the combination therapy of CDT and PDT.(a)Reproduced from Ref.[43]with permission of American Chemical Society,?2016;(b)reproduced from Ref.[45]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2018;(c)reproduced from Ref.[46]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2020;(d)reproduced from Ref.[47]with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2019.

    (2) Risk of potential toxicity. In the light-triggered molecule delivery process of phototherapy, the uncontrolled burst release of drugs from nanocarriers leads to short-term toxicity,while slow and incomplete metabolism of nanomaterials may result in longterm toxicity [121]. Furthermore, the untargeted biological distribution of light-responsive nanotherapeutic agents may cause sunlight-exposure-induced systemic toxicity. In order to realize precise controllable cancer phototherapy, an ideal nanomedicine should only be activated at the tumor site, and should maintain an ‘‘OFF” state in normal tissues. Therefore, the development of activatable phototherapeutic agents that can respond to the typical characteristics of the tumor microenvironment is an effective way to address the issue of phototoxicity.

    (3)Clinical transformation.In order to achieve multifunctional cancer therapy, nanomaterials are usually complex in both design and composition, which undoubtedly introduces difficulties into their clinical transformation. In addition, due to the unknown toxicity mechanism of some newly developed nanomaterials, the clinical application of these nanomaterials requires complex toxicity-assessment procedures.

    Acknowledgments

    This work was supported by the National Natural Science Foundation of China (32000991 and 51873150), the Young Elite Scientists Sponsorship Program by Tianjin (TJSQNTJ-2020-02), the Key Project of Tianjin Foundational Research(Jing–Jin–Ji)Program(19JCZDJC64100), and the Tianjin Research Innovation Project for Postgraduate Students (2020YJSB130).

    Compliance with ethics guidelines

    Xu Zhang, Sheng Wang, Guohui Cheng, Peng Yu, and Jin Chang declare that they have no conflict of interest or financial conflicts to disclose.

    日韩av免费高清视频| 中文乱码字字幕精品一区二区三区| 狂野欧美白嫩少妇大欣赏| 久久久久久人妻| 赤兔流量卡办理| 精品酒店卫生间| 国产成人精品在线电影| 在线观看免费日韩欧美大片 | 精品人妻一区二区三区麻豆| 免费大片黄手机在线观看| 欧美日本中文国产一区发布| 免费观看在线日韩| 精品国产乱码久久久久久小说| 国产午夜精品久久久久久一区二区三区| 亚洲精品色激情综合| 国产成人a∨麻豆精品| 欧美3d第一页| kizo精华| 天天躁夜夜躁狠狠久久av| 亚州av有码| 亚洲成人手机| 亚洲精品乱码久久久v下载方式| 欧美+日韩+精品| 母亲3免费完整高清在线观看 | 18禁动态无遮挡网站| 麻豆精品久久久久久蜜桃| 成人二区视频| 国产乱人偷精品视频| 欧美精品高潮呻吟av久久| 日韩一区二区视频免费看| 在线播放无遮挡| 人妻制服诱惑在线中文字幕| 国产av码专区亚洲av| 制服诱惑二区| av又黄又爽大尺度在线免费看| 免费av中文字幕在线| 亚洲婷婷狠狠爱综合网| 欧美精品亚洲一区二区| 国产 精品1| 亚洲国产精品成人久久小说| 最近2019中文字幕mv第一页| 国产日韩欧美视频二区| 热re99久久精品国产66热6| 中文字幕免费在线视频6| 国产一区有黄有色的免费视频| 久久久a久久爽久久v久久| 久久精品熟女亚洲av麻豆精品| 免费黄频网站在线观看国产| 国产成人午夜福利电影在线观看| 成年人免费黄色播放视频| 久久女婷五月综合色啪小说| 国产成人精品无人区| 69精品国产乱码久久久| 久久久国产一区二区| 大片免费播放器 马上看| 午夜激情福利司机影院| 内地一区二区视频在线| 国产一区有黄有色的免费视频| 不卡视频在线观看欧美| 国产精品国产av在线观看| 人妻一区二区av| 亚洲五月色婷婷综合| 人妻少妇偷人精品九色| 亚洲精品日本国产第一区| 国产乱来视频区| 欧美成人午夜免费资源| 欧美精品高潮呻吟av久久| 精品一品国产午夜福利视频| 欧美激情 高清一区二区三区| 久久精品人人爽人人爽视色| 国产成人精品无人区| 日本与韩国留学比较| 日本wwww免费看| 九色成人免费人妻av| 91久久精品国产一区二区成人| 国产一级毛片在线| av有码第一页| 一本色道久久久久久精品综合| 精品久久久精品久久久| 欧美97在线视频| 午夜福利在线观看免费完整高清在| 一级毛片 在线播放| 王馨瑶露胸无遮挡在线观看| 国产亚洲av片在线观看秒播厂| 国产男女超爽视频在线观看| 国产欧美另类精品又又久久亚洲欧美| 国产精品久久久久久精品电影小说| 精品久久久噜噜| 亚洲第一区二区三区不卡| 国产精品国产三级国产av玫瑰| 春色校园在线视频观看| 成年女人在线观看亚洲视频| 免费高清在线观看视频在线观看| 一区二区三区四区激情视频| 极品少妇高潮喷水抽搐| 三级国产精品欧美在线观看| 国产国拍精品亚洲av在线观看| 欧美日韩av久久| 日韩一区二区视频免费看| 一级,二级,三级黄色视频| 欧美少妇被猛烈插入视频| 国产黄色视频一区二区在线观看| kizo精华| 亚洲熟女精品中文字幕| 一级毛片我不卡| 国产一区有黄有色的免费视频| 寂寞人妻少妇视频99o| 啦啦啦在线观看免费高清www| 日韩亚洲欧美综合| 亚洲精华国产精华液的使用体验| 国产一区二区在线观看日韩| 中文字幕精品免费在线观看视频 | kizo精华| 亚洲欧美成人综合另类久久久| av卡一久久| 新久久久久国产一级毛片| 天堂中文最新版在线下载| 国产欧美另类精品又又久久亚洲欧美| 久久精品国产亚洲网站| 免费大片黄手机在线观看| 国产精品秋霞免费鲁丝片| 嫩草影院入口| 一级爰片在线观看| 亚洲精品视频女| 国产日韩一区二区三区精品不卡 | 亚洲av欧美aⅴ国产| 免费av中文字幕在线| 国产日韩欧美视频二区| 伊人久久精品亚洲午夜| 成人国语在线视频| 亚洲五月色婷婷综合| 欧美激情国产日韩精品一区| 极品人妻少妇av视频| 日韩免费高清中文字幕av| 国产日韩欧美在线精品| 国产精品偷伦视频观看了| 久久99热这里只频精品6学生| 亚洲成人一二三区av| av有码第一页| 国产精品免费大片| 欧美成人精品欧美一级黄| 国产精品.久久久| 日本vs欧美在线观看视频| 国内精品宾馆在线| 两个人免费观看高清视频| av播播在线观看一区| 亚洲av日韩在线播放| 丰满乱子伦码专区| 18禁观看日本| 国产成人精品久久久久久| 九色成人免费人妻av| 久久人人爽人人片av| 久久久久久久久久成人| 久久久久久伊人网av| 大香蕉97超碰在线| 人人妻人人爽人人添夜夜欢视频| 搡女人真爽免费视频火全软件| 久久午夜福利片| 国产成人精品一,二区| 久久久亚洲精品成人影院| 综合色丁香网| 午夜影院在线不卡| freevideosex欧美| 99九九在线精品视频| 亚洲第一av免费看| 一区在线观看完整版| 精品国产国语对白av| 午夜影院在线不卡| 欧美人与性动交α欧美精品济南到 | tube8黄色片| 中文天堂在线官网| 9色porny在线观看| 日本欧美视频一区| 五月伊人婷婷丁香| a级毛片黄视频| 国产成人一区二区在线| 国产伦精品一区二区三区视频9| 一本一本综合久久| 黄色一级大片看看| 日本猛色少妇xxxxx猛交久久| 建设人人有责人人尽责人人享有的| 尾随美女入室| 日本与韩国留学比较| 亚州av有码| 乱码一卡2卡4卡精品| 夜夜看夜夜爽夜夜摸| 成人国语在线视频| 啦啦啦中文免费视频观看日本| 在现免费观看毛片| 亚洲av成人精品一区久久| 人妻夜夜爽99麻豆av| 女人精品久久久久毛片| 欧美日韩国产mv在线观看视频| 丰满饥渴人妻一区二区三| 日本欧美视频一区| 夜夜看夜夜爽夜夜摸| 精品久久久久久久久亚洲| 综合色丁香网| 国产精品一二三区在线看| 久久毛片免费看一区二区三区| 亚洲精品亚洲一区二区| 久久青草综合色| 亚洲不卡免费看| 久久久国产精品麻豆| 午夜福利在线观看免费完整高清在| 免费久久久久久久精品成人欧美视频 | 精品视频人人做人人爽| 三级国产精品欧美在线观看| 搡女人真爽免费视频火全软件| 免费大片18禁| 国产精品99久久99久久久不卡 | 人人妻人人澡人人爽人人夜夜| 69精品国产乱码久久久| 亚洲国产欧美在线一区| 国产片特级美女逼逼视频| 秋霞伦理黄片| 精品国产一区二区三区久久久樱花| 国产精品秋霞免费鲁丝片| 啦啦啦中文免费视频观看日本| 国产亚洲精品久久久com| 国产日韩欧美亚洲二区| videosex国产| 欧美日韩在线观看h| 国产亚洲最大av| 亚洲精品中文字幕在线视频| 99精国产麻豆久久婷婷| 桃花免费在线播放| 夜夜骑夜夜射夜夜干| 欧美一级a爱片免费观看看| 美女脱内裤让男人舔精品视频| 九九久久精品国产亚洲av麻豆| 黑人猛操日本美女一级片| 日本欧美国产在线视频| 久久久久久久大尺度免费视频| 欧美日韩一区二区视频在线观看视频在线| 国产成人91sexporn| av电影中文网址| 久久久久久久亚洲中文字幕| 亚洲欧美精品自产自拍| 精品久久久久久电影网| 亚洲色图综合在线观看| 国产精品蜜桃在线观看| 亚洲三级黄色毛片| 超色免费av| 国产精品三级大全| 久久久久国产精品人妻一区二区| 午夜免费观看性视频| 国产免费一级a男人的天堂| a级毛片免费高清观看在线播放| 国产日韩欧美视频二区| 亚洲性久久影院| 欧美人与性动交α欧美精品济南到 | 日本欧美国产在线视频| 在线观看一区二区三区激情| 国产av码专区亚洲av| 亚洲综合色惰| 2021少妇久久久久久久久久久| 中文字幕亚洲精品专区| 国产精品久久久久久久电影| 久久久久视频综合| 免费日韩欧美在线观看| 国产淫语在线视频| 高清黄色对白视频在线免费看| 桃花免费在线播放| 日本欧美国产在线视频| 黄色欧美视频在线观看| 国产精品不卡视频一区二区| 成人毛片a级毛片在线播放| 亚洲av福利一区| 一区二区三区乱码不卡18| 高清毛片免费看| 国产免费现黄频在线看| 色婷婷久久久亚洲欧美| 在线观看一区二区三区激情| 22中文网久久字幕| 国产国拍精品亚洲av在线观看| 丝袜脚勾引网站| 人妻 亚洲 视频| 亚洲av国产av综合av卡| 丰满迷人的少妇在线观看| 国产69精品久久久久777片| 人妻一区二区av| 欧美日韩精品成人综合77777| 精品国产国语对白av| 日韩电影二区| 国产极品天堂在线| 搡老乐熟女国产| 婷婷成人精品国产| 成年美女黄网站色视频大全免费 | 夫妻性生交免费视频一级片| 亚洲色图综合在线观看| 一个人看视频在线观看www免费| 一级片'在线观看视频| 亚洲精品乱码久久久v下载方式| 大香蕉久久成人网| 亚洲欧美一区二区三区国产| 人成视频在线观看免费观看| 精品卡一卡二卡四卡免费| 久久精品国产亚洲av涩爱| av一本久久久久| 一级爰片在线观看| 97超视频在线观看视频| 老女人水多毛片| 搡女人真爽免费视频火全软件| 超碰97精品在线观看| 国产精品 国内视频| 最近手机中文字幕大全| 国产高清不卡午夜福利| 少妇猛男粗大的猛烈进出视频| 高清视频免费观看一区二区| 国产精品女同一区二区软件| 亚洲精华国产精华液的使用体验| 男女国产视频网站| 青春草视频在线免费观看| 桃花免费在线播放| videos熟女内射| 成人国产麻豆网| 久久精品久久久久久久性| 日韩一本色道免费dvd| 色婷婷久久久亚洲欧美| 亚洲欧美一区二区三区黑人 | 国产视频首页在线观看| 欧美变态另类bdsm刘玥| 国产亚洲午夜精品一区二区久久| 在线观看免费视频网站a站| 一级毛片 在线播放| 亚洲人成网站在线播| 街头女战士在线观看网站| 午夜激情av网站| 日本黄大片高清| 午夜福利影视在线免费观看| 国产男女超爽视频在线观看| 99九九在线精品视频| 伦理电影大哥的女人| 欧美日韩视频高清一区二区三区二| 亚洲人成网站在线观看播放| 亚洲精品国产色婷婷电影| 大又大粗又爽又黄少妇毛片口| 日日撸夜夜添| 啦啦啦啦在线视频资源| 全区人妻精品视频| 免费黄频网站在线观看国产| 99国产精品免费福利视频| 欧美日韩在线观看h| a级毛片免费高清观看在线播放| 午夜老司机福利剧场| 大又大粗又爽又黄少妇毛片口| a级毛片在线看网站| 青春草亚洲视频在线观看| 国产欧美日韩一区二区三区在线 | 制服人妻中文乱码| 久久久久久久大尺度免费视频| 永久网站在线| 中文字幕最新亚洲高清| 中文字幕免费在线视频6| 满18在线观看网站| 多毛熟女@视频| 女的被弄到高潮叫床怎么办| 欧美xxⅹ黑人| 成人影院久久| 丝瓜视频免费看黄片| 亚洲精品aⅴ在线观看| 天美传媒精品一区二区| 久久国产精品男人的天堂亚洲 | 狂野欧美激情性xxxx在线观看| 一级毛片aaaaaa免费看小| 777米奇影视久久| 久久国产精品男人的天堂亚洲 | 国产片特级美女逼逼视频| 在线看a的网站| 老司机亚洲免费影院| 日本-黄色视频高清免费观看| 最后的刺客免费高清国语| 色网站视频免费| 亚洲国产最新在线播放| 插逼视频在线观看| 2021少妇久久久久久久久久久| 国产精品久久久久久久电影| 女性被躁到高潮视频| 亚洲av日韩在线播放| 精品久久久精品久久久| 国产精品99久久久久久久久| 午夜福利网站1000一区二区三区| 制服丝袜香蕉在线| 成人国语在线视频| 热re99久久精品国产66热6| 人人妻人人澡人人爽人人夜夜| 自拍欧美九色日韩亚洲蝌蚪91| 51国产日韩欧美| 久久亚洲国产成人精品v| 亚洲综合色惰| 亚洲四区av| 欧美激情 高清一区二区三区| 99热网站在线观看| 午夜激情福利司机影院| videosex国产| 欧美另类一区| 飞空精品影院首页| 色网站视频免费| 亚洲精品色激情综合| 久久久精品区二区三区| 国产成人精品久久久久久| 久久青草综合色| 免费人成在线观看视频色| 国产男人的电影天堂91| 久久久欧美国产精品| 丰满迷人的少妇在线观看| 欧美激情国产日韩精品一区| 久久韩国三级中文字幕| 国产av码专区亚洲av| 免费日韩欧美在线观看| 视频在线观看一区二区三区| 91精品国产九色| 婷婷色综合大香蕉| 99久久人妻综合| 日韩大片免费观看网站| 日韩一区二区视频免费看| 中文字幕最新亚洲高清| 日韩,欧美,国产一区二区三区| 在线观看免费高清a一片| 久久女婷五月综合色啪小说| 一本一本综合久久| 视频在线观看一区二区三区| 999精品在线视频| 99热国产这里只有精品6| 久久精品国产a三级三级三级| 中国三级夫妇交换| 久久久精品免费免费高清| 国产日韩一区二区三区精品不卡 | 国产极品粉嫩免费观看在线 | 亚洲色图 男人天堂 中文字幕 | 精品久久久噜噜| av视频免费观看在线观看| 日韩强制内射视频| 伊人久久精品亚洲午夜| 性色avwww在线观看| 国产成人精品无人区| 97精品久久久久久久久久精品| 街头女战士在线观看网站| 三上悠亚av全集在线观看| 国产伦精品一区二区三区视频9| 少妇精品久久久久久久| 伦理电影免费视频| 国产在线免费精品| 最近手机中文字幕大全| 国产精品 国内视频| 国产69精品久久久久777片| 新久久久久国产一级毛片| 日日撸夜夜添| 亚洲精品久久成人aⅴ小说 | 成人午夜精彩视频在线观看| 久久人人爽av亚洲精品天堂| 成人亚洲精品一区在线观看| 五月天丁香电影| 最新的欧美精品一区二区| 久热久热在线精品观看| 日韩大片免费观看网站| 午夜免费男女啪啪视频观看| 亚洲精品av麻豆狂野| 久久久久久久久久人人人人人人| 亚洲国产精品成人久久小说| 亚洲美女黄色视频免费看| 蜜桃久久精品国产亚洲av| 各种免费的搞黄视频| 99久久精品一区二区三区| 天堂8中文在线网| 国产精品一区二区在线观看99| 在现免费观看毛片| 国产黄频视频在线观看| 亚洲不卡免费看| 亚洲国产欧美在线一区| 国产毛片在线视频| 好男人视频免费观看在线| 在线看a的网站| 麻豆精品久久久久久蜜桃| 久久精品久久久久久噜噜老黄| 午夜福利视频在线观看免费| 亚洲精品国产色婷婷电影| 国产欧美亚洲国产| 免费日韩欧美在线观看| 黄片无遮挡物在线观看| 久久精品国产鲁丝片午夜精品| 国产亚洲欧美精品永久| 欧美人与善性xxx| 99九九在线精品视频| 美女大奶头黄色视频| 欧美亚洲日本最大视频资源| 97超视频在线观看视频| 免费看不卡的av| 亚洲精品av麻豆狂野| 天堂中文最新版在线下载| 一边摸一边做爽爽视频免费| 免费播放大片免费观看视频在线观看| 精品一区二区三卡| 青青草视频在线视频观看| 国产高清不卡午夜福利| 97精品久久久久久久久久精品| 少妇被粗大猛烈的视频| 欧美97在线视频| 青青草视频在线视频观看| 久久久久久久久久人人人人人人| 51国产日韩欧美| 99热国产这里只有精品6| 国产免费又黄又爽又色| 日韩成人av中文字幕在线观看| 人体艺术视频欧美日本| 亚洲五月色婷婷综合| 国产国语露脸激情在线看| 国产成人精品一,二区| 黑人欧美特级aaaaaa片| 全区人妻精品视频| 国产亚洲一区二区精品| 美女国产视频在线观看| 国产又色又爽无遮挡免| 好男人视频免费观看在线| 天天躁夜夜躁狠狠久久av| 在线亚洲精品国产二区图片欧美 | 国产精品麻豆人妻色哟哟久久| 一本—道久久a久久精品蜜桃钙片| 香蕉精品网在线| 国产老妇伦熟女老妇高清| 午夜福利网站1000一区二区三区| 99久国产av精品国产电影| 男女免费视频国产| 简卡轻食公司| 91久久精品电影网| 免费黄色在线免费观看| 欧美日韩视频精品一区| 乱人伦中国视频| 中文精品一卡2卡3卡4更新| 日韩一区二区视频免费看| 黑人猛操日本美女一级片| 日韩精品免费视频一区二区三区 | 日本av免费视频播放| 18禁观看日本| 日本vs欧美在线观看视频| 久久久a久久爽久久v久久| 又粗又硬又长又爽又黄的视频| 秋霞伦理黄片| 狂野欧美激情性xxxx在线观看| 国产探花极品一区二区| 男男h啪啪无遮挡| 国产高清不卡午夜福利| 国内精品宾馆在线| a级毛片在线看网站| 日韩一区二区三区影片| 男女边摸边吃奶| 免费观看的影片在线观看| 国产有黄有色有爽视频| 国语对白做爰xxxⅹ性视频网站| 亚洲成人av在线免费| 国产精品久久久久久av不卡| 少妇高潮的动态图| xxxhd国产人妻xxx| 麻豆成人av视频| 欧美日韩视频高清一区二区三区二| 在线播放无遮挡| 一级二级三级毛片免费看| 中国美白少妇内射xxxbb| 久久午夜综合久久蜜桃| 蜜桃在线观看..| 制服人妻中文乱码| 日日摸夜夜添夜夜添av毛片| 亚洲av电影在线观看一区二区三区| 亚洲精华国产精华液的使用体验| 一级二级三级毛片免费看| 日韩,欧美,国产一区二区三区| 精品少妇久久久久久888优播| 成年人免费黄色播放视频| 91久久精品国产一区二区成人| 性高湖久久久久久久久免费观看| 亚洲高清免费不卡视频| 中文字幕人妻丝袜制服| 简卡轻食公司| 国产极品天堂在线| 久久精品国产鲁丝片午夜精品| 青春草亚洲视频在线观看| 肉色欧美久久久久久久蜜桃| 香蕉精品网在线| 亚洲欧洲日产国产| 亚洲成人av在线免费| 国产69精品久久久久777片| 欧美精品国产亚洲| 性高湖久久久久久久久免费观看| 亚洲精品成人av观看孕妇| 最近最新中文字幕免费大全7| 国产探花极品一区二区| 黄色视频在线播放观看不卡| 日本vs欧美在线观看视频| 高清视频免费观看一区二区| a级毛片黄视频| 亚洲美女视频黄频| 日日摸夜夜添夜夜添av毛片| 色婷婷久久久亚洲欧美| 亚洲av成人精品一二三区| 久久亚洲国产成人精品v| 老司机亚洲免费影院| 少妇人妻 视频| 国产毛片在线视频| 亚洲国产精品成人久久小说| www.色视频.com| 在线精品无人区一区二区三| 丝袜脚勾引网站| 桃花免费在线播放| 日韩,欧美,国产一区二区三区| 久久精品夜色国产| 一本色道久久久久久精品综合| 九草在线视频观看| 麻豆乱淫一区二区| 欧美精品国产亚洲| 国产精品一区二区在线观看99| 啦啦啦啦在线视频资源| 一级a做视频免费观看| 人体艺术视频欧美日本| 晚上一个人看的免费电影|